Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs ZCMD✓SelectedUSD · ZCMDGSK vs ZCMD performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs ZCMD

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.7%
ZCMD return
-100.0%
Excess return
+152.7%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioZCMDExcessAlpha
1D-0.1%-3.7%+3.6%-0.1%
7D-5.3%-12.8%+7.4%-5.3%
30D-3.7%-41.4%+37.8%-3.7%
3M-7.3%-59.1%+51.9%-7.3%
6M-4.2%-99.7%+95.5%-2.4%
YTD+0.9%-99.9%+100.7%+3.2%
1Y+7.3%-99.9%+107.2%+10.0%
3Y+52.7%-100.0%+152.7%+59.5%
All+52.7%-100.0%+152.7%+59.5%

Cumulative growth

Daily Returns

Daily percentage return beside ZCMD.

Daily Out/Under-Performance

Portfolio return minus ZCMD return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ZCMD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded ZCMD wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling